![](/img/cover-not-exists.png)
Efficacy and safety of ipragliflozin as add-on therapy to insulin in Japanese patients with type 2 diabetes mellitus (IOLITE): a 36-week, open-label extension of a 16-week, randomized, placebo-controlled, double-blind study
Ishihara, Hisamitsu, Yamaguchi, Susumu, Nakao, Ikko, Asahina, Seitaro, Sakatani, TaishiLanguage:
english
Journal:
Diabetology International
DOI:
10.1007/s13340-018-0359-x
Date:
July, 2018
File:
PDF, 760 KB
english, 2018